It contains an inhaled corticosteroid called budesonide that helps alleviate airway inflammation and a long-acting bronchodilator called formoterol fumarate dihydrate that helps keep airways open.

AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic obstructive ...

Budesonide 160mcg, glycopyrrolate 9mcg, formoterol fumarate 4.8mcg; per inhalation; metered-dose inhaler with dose counter. is supplied as a pressurized aluminum canister with an attached dose ...

Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) can cause side effects that range from mild to serious. If side effects from Breztri become ...

Bevespi Aerosphere (glycopyrronium+formoterol) demonstrated a statistically significant improvement in lung function compared with its monotherapy components and placebo, taken twice daily through ...